Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment. (2021)
Attributed to:
Mesenchymal stem cell-derived extracellular vesicles as a cell-free therapy for ARDS.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1210/clinem/dgaa403
PubMed Identifier: 32617576
Publication URI: http://europepmc.org/abstract/MED/32617576
Type: Journal Article/Review
Volume: 106
Parent Publication: The Journal of clinical endocrinology and metabolism
Issue: 1
ISSN: 0021-972X